Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine.
European journal of case reports in internal medicine(2022)
Abstract
We present a case of newly diagnosed myasthenia gravis after administration of the mRNA-1273 SARS-CoV-2 vaccine.mRNA-1273 vaccination against SARS-CoV-2 may exacerbate subclinical cases of myasthenia gravis.Recognition of new vaccine side effects may guide the selection of vulnerable patients.
MoreTranslated text
Key words
Myasthenia gravis,SARS-CoV-2,mRNA-1273
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined